share_log

2 More Directors Depart from SoftBank Group: FT

2 More Directors Depart from SoftBank Group: FT

又有2名董事離開軟銀集團：FT
Benzinga Real-time News ·  2021/05/21 12:53
  • SoftBank Group Corp (OTC: SFTBY) (OTC: SFTBF) directors Yuko Kawamoto and Ron Fisher will depart as board members, the Financial Times reports.
  • High pressure from U.S. hedge fund Elliott Management and other investors over better corporate governance practices led to the election of Kawamoto.
  • Kawamoto had reportedly challenged its founder Masayoshi Son on internal control issues.
  • SoftBank’s first woman director Kawamoto will become National Personnel Authority commissioner. SoftBank has selected another female director to replace her.
  • Fisher, who supervised most of SoftBank’s WeWork investment, will depart after 26 years. He reportedly worked the closest with management on its strategy and growth plans.
  • SoftBank has defended the resignation as Fisher’s decision and was unrelated to the WeWork investment.
  • Fast Retailing Co Ltd (OTC: FRCOY) CEO Tadashi Yanai and Alibaba Group Holding Ltd (NYSE: BABA) co-founder Jack Ma resigned as directors as SoftBank started investing in technology start-ups through its $100 billion Vision Fund. 
  • Arm CEO Simon Segars will depart after SoftBank sold the U.K. company to NVIDIA Corp (NASDAQ: NVDA).
  • Price action: SFTBY shares traded lower by 1.47% at $39 on the last check Friday.
  • 軟銀集團(SoftBank Group Corp)據英國《金融時報》報道，(場外交易代碼：SFTBY)(場外交易代碼：SFTBF)董事川本裕子(Yuko Kawamoto)和羅恩·費舍爾(Ron Fisher)將辭去董事會成員一職。
  • 來自美國對衝基金埃利奧特管理公司(Elliott Management)和其他投資者對改善公司治理做法的巨大壓力，導致川本當選。
  • 據報道，川本曾就內部控制問題挑戰其創始人孫正義(Masayoshi Son)。
  • 軟銀首位女性董事川本將出任國家人事管理局局長。軟銀已經選擇了另一位女性董事來接替她。
  • 費舍爾負責監督軟銀在WeWork的大部分投資，他將在任職26年後離職。據報道，他與管理層在戰略和增長計劃方面的合作最密切。
  • 軟銀為費舍爾的辭職辯護，稱這是費舍爾的決定，與WeWork的投資無關。
  • 迅銷股份有限公司(場外交易代碼：FRCOY)首席執行官柳井正和阿里巴巴集團控股有限公司(紐約證券交易所股票代碼：BABA)聯合創始人馬雲辭去董事職務，因為軟銀開始通過其1000億美元的願景基金投資科技初創企業。
  • ARM首席執行官西蒙·西格斯將離職，此前軟銀將這家英國公司出售給NVIDIA公司(納斯達克股票代碼：NVDA)
  • 價格行動：SFTBY股價在週五的最後一次檢查中下跌1.47%，至39美元。
声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論